<?xml
version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel xml:lang="fr">
	<title>Joseph Larmarange</title>
	<link>https://joseph.larmarange.net/</link>
	<description>D&#233;mographe en sant&#233; publique, directeur de recherche HDR &#224; l'IRD,directeur adjoint du Ceped (UMR 196 Universit&#233; Paris Cit&#233;, IRD, Universit&#233; Sorbonne Paris Nord, Inserm)</description>
	<language>fr</language>
	<generator>SPIP - www.spip.net</generator>
	<atom:link href="http://joseph.larmarange.net/spip.php?id_mot=7&amp;page=backend" rel="self" type="application/rss+xml" />

	<image>
		<title>Joseph Larmarange</title>
		<url>http://joseph.larmarange.net/local/cache-vignettes/L144xH52/joseph_larmarange_site-6e82f.svg?1649686173</url>
		<link>https://joseph.larmarange.net/</link>
		<height>52</height>
		<width>144</width>
	</image>



<item xml:lang="en">
		<title>Comparing modelled HIV incidence estimates with empirical HIV incidence observations in high-burden HIV African epidemic settings: systematic review and meta-regression</title>
		<link>http://joseph.larmarange.net/comparing-modelled-hiv-incidence</link>
		<guid isPermaLink="true">http://joseph.larmarange.net/comparing-modelled-hiv-incidence</guid>
		<dc:date>2026-02-10T17:15:53Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>Incidence du VIH</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>Mod&#233;lisation</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Oliver Stevens, Michelle Moffa, Joanne H. Hunt, Kyle Patel, Tihitna Aytenfisu, Adam Akullian, Rebecca L Anderson, Peter Bock, Amelia C Crampin, Sian Floyd, Simon Gregson, Richard J Hayes, Collins Iwuji, Ivan Kasamba, Daniel Kwaro, Joseph Larmarange, Shahin Lockman, Denna Michael, Louisa Moorhouse, Joseph Mugisha, Elphas Okango, Maya L Petersen, Victor Ssempijja, Emma Slaymaker, Frank Tanser, Cari van Schalkwyk, M. Kate Grabowski, Jeffrey W. Imai-Eaton &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Background &lt;br class='autobr' /&gt;
HIV&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="http://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="http://joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Incidence-du-VIH-+" rel="tag"&gt;Incidence du VIH&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Modelisation-+" rel="tag"&gt;Mod&#233;lisation&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L150xH112/21c2fcee-4d67-40a5-86ac-45a0f0482045-abbe7.jpg?1770743757' class='spip_logo spip_logo_right' width='150' height='112' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5503917&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05503914v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-6fdcce37-0f350.png?1770899495' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05503914v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Comparing modelled HIV incidence estimates with empirical HIV incidence observations in high-burden HIV African epidemic settings: systematic review and meta-regression&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731644810&#034; class=&#034;hal-auteur&#034;&gt;Oliver Stevens&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Michelle+Moffa&#034; class=&#034;hal-auteur&#034;&gt;Michelle Moffa&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Joanne+Hunt&#034; class=&#034;hal-auteur&#034;&gt;Joanne Hunt&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Kyle+Patel&#034; class=&#034;hal-auteur&#034;&gt;Kyle Patel&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Tihitna+Aytenfisu&#034; class=&#034;hal-auteur&#034;&gt;Tihitna Aytenfisu&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Adam+Akullian&#034; class=&#034;hal-auteur&#034;&gt;Adam Akullian&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731644811&#034; class=&#034;hal-auteur&#034;&gt;Rebecca Anderson&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Peter+Bock&#034; class=&#034;hal-auteur&#034;&gt;Peter Bock&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Amelia+Crampin&#034; class=&#034;hal-auteur&#034;&gt;Amelia Crampin&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Sian+Floyd&#034; class=&#034;hal-auteur&#034;&gt;Sian Floyd&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Simon+Gregson&#034; class=&#034;hal-auteur&#034;&gt;Simon Gregson&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Richard+Hayes&#034; class=&#034;hal-auteur&#034;&gt;Richard Hayes&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Collins+Iwuji&#034; class=&#034;hal-auteur&#034;&gt;Collins Iwuji&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Ivan+Kasamba&#034; class=&#034;hal-auteur&#034;&gt;Ivan Kasamba&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Daniel+Kwaro&#034; class=&#034;hal-auteur&#034;&gt;Daniel Kwaro&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Shahin+Lockman&#034; class=&#034;hal-auteur&#034;&gt;Shahin Lockman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Denna+Michael&#034; class=&#034;hal-auteur&#034;&gt;Denna Michael&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731644812&#034; class=&#034;hal-auteur&#034;&gt;Louisa Moorhouse&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Joseph+Mugisha&#034; class=&#034;hal-auteur&#034;&gt;Joseph Mugisha&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Elphas+Okango&#034; class=&#034;hal-auteur&#034;&gt;Elphas Okango&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Maya+Petersen&#034; class=&#034;hal-auteur&#034;&gt;Maya Petersen&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Victor+Ssempijja&#034; class=&#034;hal-auteur&#034;&gt;Victor Ssempijja&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Emma+Slaymaker&#034; class=&#034;hal-auteur&#034;&gt;Emma Slaymaker&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Frank+Tanser&#034; class=&#034;hal-auteur&#034;&gt;Frank Tanser&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Cari+van+Schalkwyk&#034; class=&#034;hal-auteur&#034;&gt;Cari van Schalkwyk&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=M.+Kate+Grabowski&#034; class=&#034;hal-auteur&#034;&gt;M. Kate Grabowski&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Jeffrey+Imai-Eaton&#034; class=&#034;hal-auteur&#034;&gt;Jeffrey Imai-Eaton&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;2026&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-undefined&#034;&gt;Pr&#233;-publication, Document de travail&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05503914v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05503914&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Oliver Stevens, Michelle Moffa, Joanne H. Hunt, Kyle Patel, Tihitna Aytenfisu, Adam Akullian, Rebecca L Anderson, Peter Bock, Amelia C Crampin, Sian Floyd, Simon Gregson, Richard J Hayes, Collins Iwuji, Ivan Kasamba, Daniel Kwaro, Joseph Larmarange, Shahin Lockman, Denna Michael, Louisa Moorhouse, Joseph Mugisha, Elphas Okango, Maya L Petersen, Victor Ssempijja, Emma Slaymaker, Frank Tanser, Cari van Schalkwyk, M. Kate Grabowski, Jeffrey W. Imai-Eaton&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;HIV incidence in sub-Saharan Africa has declined substantially since 2000 according to epidemic estimates published by UNAIDS. These estimates, derived by fitting mathematical models to national surveillance data, guide HIV programmes and epidemic response strategies. We assessed whether the level and age distribution of HIV incidence from modelled estimates were consistent with empirical HIV incidence observations, and whether incidence levels and trends were systematically different between study types, populations, and age groups.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;We conducted an updated systematic review of adult HIV incidence data from sub-Saharan Africa published July 2019-February 2024 by searching Scopus, PubMed, Embase, and OVID databases, and combined with earlier systematic review data. We matched empirical incidence measurements between 1990-2023 to UNAIDS HIV incidence estimates by study area, sex, age group, and year. We used Bayesian mixed-effect Poisson regression to estimate (1) incidence rate ratios (IRR) between empirical observations and matched modelled incidence estimates adjusted for sex, year and study type/population; and (2) time trends in age-specific incidence from population-based cohort studies and household surveys.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;3560 HIV empirical incidence measurements were included from 179 studies conducted in 21 countries, comprising 23,000 new infections and 3.1 million person-years. Incidence observations from nationally-representative household surveys (IRR 1.07 95%CI 0.68, 1.67) and population-representative study populations (IRR 0.98 95%CI 0.51, 1.89) were not significantly different from matched modelled estimates, and declined at the same rate as modelled estimates (annual aRR 0.99 95%CI 0.98, 1.01). Studies among pregnant women (IRR 2.60 95%CI 1.58, 4.28), control arms of clinical trials (IRR 3.01 95%CI 1.90, 4.77) and key populations (FSW IRR: 6.46 95%CI 4.18, 10.00; MSM 44.02 95%CI 27.35, 70.87) had significantly higher incidence than modelled total population incidence estimates. Across population cohorts in Eastern and Southern Africa, HIV incidence among adults aged 15-49 declined by 75-90% between 2010-2023, and declined 7% (95%CI 4-10%) faster per year among young adults 15-24 compared to age 25+ years. Modelled incidence declined similarly to cohort data, but did not reflect the aging of the epidemic.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Observed incidence in population-representative studies in sub-Saharan Africa has declined steeply. Mathematical models that infer incidence from cross-sectional HIV surveillance data estimated the same incidence level and decline over time as population-representative studies. Studies with non-representative inclusion criteria had significantly higher incidence, including those among pregnant women and most HIV prevention/vaccine efficacy trials. The age pattern of incidence in modelled estimates should be reconsidered to capture the aging of the epidemic indicated by cohort studies.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Knowledge, attitudes and practices relating to HIV self-testing following its introduction in the Bas-Sassandra region of C&#244;te d'Ivoire: the case of the ATLAS project</title>
		<link>http://joseph.larmarange.net/knowledge-attitudes-and-practices</link>
		<guid isPermaLink="true">http://joseph.larmarange.net/knowledge-attitudes-and-practices</guid>
		<dc:date>2026-01-30T17:14:26Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>ATLAS</dc:subject>
		<dc:subject>Autotests VIH</dc:subject>
		<dc:subject>Connaissance du VIH/SIDA</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Arlette Simo Fotso, Christian Koukobo, Romain Silhol, Ars&#232;ne Kouassi Kra, Marie-Claude Boily, Anthony Vautier, Joseph Larmarange on behalf of the ATLAS team &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Background &lt;br class='autobr' /&gt;
Awareness of HIV status is crucial for accessing HIV care and prevention but remains suboptimal in West Africa. The ATLAS initiative, launched in C&#244;te d'Ivoire, Mali, and Senegal, addressed this gap by distributing approximately 380,000 HIV self-testing (HIVST) kits from 2019 to 2021, primarily to key&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="http://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="http://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-ATLAS-+" rel="tag"&gt;ATLAS&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Autotests-VIH-+" rel="tag"&gt;Autotests VIH&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Connaissance-du-VIH-SIDA-+" rel="tag"&gt;Connaissance du VIH/SIDA&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L150xH112/f42dfe17-8908-4530-9735-cbc4921da513-c00cc.jpg?1769796547' class='spip_logo spip_logo_right' width='150' height='112' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5486497&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05486495v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L58xH75/thumb-885939fa-ca1c0.png?1770209287' alt=&#034;Image document&#034; width='58' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05486495v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Knowledge, attitudes and practices relating to HIV self-testing following its introduction in the Bas-Sassandra region of C&#244;te d'Ivoire: the case of the ATLAS project&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/arlette-simo-fotso&#034; class=&#034;hal-auteur&#034;&gt;Arlette Simo Fotso&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Christian+Koukobo&#034; class=&#034;hal-auteur&#034;&gt;Christian Koukobo&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Romain+Silhol&#034; class=&#034;hal-auteur&#034;&gt;Romain Silhol&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/kra-djuhe-kouassi&#034; class=&#034;hal-auteur&#034;&gt;Arsene Kra Kouassi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197204&#034; class=&#034;hal-auteur&#034;&gt;Marie-Claude Boily&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Anthony+Vautier&#034; class=&#034;hal-auteur&#034;&gt;Anthony Vautier&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;PLoS ONE&lt;/i&gt;, 2026, 21 (1), pp.e0314947. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.1371/journal.pone.0314947&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.1371/journal.pone.0314947&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05486495v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05486495&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Arlette Simo Fotso, Christian Koukobo, Romain Silhol, Ars&#232;ne Kouassi Kra, Marie-Claude Boily, Anthony Vautier, Joseph Larmarange on behalf of the ATLAS team&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Awareness of HIV status is crucial for accessing HIV care and prevention but remains suboptimal in West Africa. The ATLAS initiative, launched in C&#244;te d'Ivoire, Mali, and Senegal, addressed this gap by distributing approximately 380,000 HIV self-testing (HIVST) kits from 2019 to 2021, primarily to key populations and their social networks. This study assessed levels and correlates of Knowledge, Attitudes, and Practices (KAP) related to HIVST in the Bas-Sassandra region of C&#244;te d'Ivoire following ATLAS's introduction.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Method&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;A cross-sectional population-based survey was conducted in the Bas-Sassandra region in 2021 among individuals aged 15&#8211;49. A total of 6,271 people (3,203 men and 3,068 women) were interviewed. They were selected using a three-stage stratified sampling approach in the Bas-Sassandra region. Bivariate statistics and multivariable logistic regressions were used to assess KAP levels and the associated factors.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Although few participants reported having heard about HIVST (11%) or having used it (3%), most of them reported that if it were freely available, they would be interested/very interested in using it for themselves (76%), as well as for their sexual partners (75%). Education and wealth were positively associated with knowledge and positive attitudes towards HIVST among both men and women, whereas age was positively correlated to knowledge and use of HIVST among men only. The number of sexual partners over the last 12 months was positively associated with knowledge of HIVST and willingness to use HIVST for themselves or their sexual partners among both sexes. We also found that high HIV-related knowledge and low levels of negative attitude were positively associated with positive attitudes towards HIVST, while exposure to the media appeared to be correlated to knowledge of HIVST.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The high level of positive attitudes towards HIVST calls for a scaling up of access to HIVST in the region. Specific attention to groups with the worst KAP, such as the less educated, the poor or those with more HIV-related negative attitude, could enhance the success of such initiatives.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Adoption of HIV preexposure prophylaxis (PrEP) among female sex workers (FSWs) in C&#244;te d'Ivoire: complex trajectories and early adopters</title>
		<link>http://joseph.larmarange.net/adoption-of-hiv-preexposure</link>
		<guid isPermaLink="true">http://joseph.larmarange.net/adoption-of-hiv-preexposure</guid>
		<dc:date>2025-07-15T15:10:30Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Analyse de s&#233;quences</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Joseph Larmarange, M&#233;lanie Plazy, Marcellin Nouaman, Evelyne Kissi, Rose-Marcelle Dedocoton, Patrick Coffie, Serge Eholi&#233;, Valentine Becquet &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
BACKGROUND: The ANRS 12381 PRINCESSE project (11/2019-06/2023) enrolled 489 FSWs and implemented community-based sexual and reproductive health care, including PrEP, delivered through mobile clinics at prostitution sites in the San Pedro region. This presentation aims to describe PrEP trajectories and the factors associated with&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="http://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="http://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Analyse-de-sequences-+" rel="tag"&gt;Analyse de s&#233;quences&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L86xH150/ias2025-a9891.png?1752596042' class='spip_logo spip_logo_right' width='86' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5163756&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05163730v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L75xH43/thumb-1a4ce10f-3d2ff.png?1752686173' alt=&#034;Image document&#034; width='75' height='43' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163730v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Adoption of HIV preexposure prophylaxis (PrEP) among female sex workers (FSWs) in C&#244;te d'Ivoire: complex trajectories and early adopters&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;IAS 2025, the 13th IAS Conference on HIV Science&lt;/i&gt;, International AIDS Society, Jul 2025, Kigali, Rwanda&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163730v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05163730&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Joseph Larmarange, M&#233;lanie Plazy, Marcellin Nouaman, Evelyne Kissi, Rose-Marcelle Dedocoton, Patrick Coffie, Serge Eholi&#233;, Valentine Becquet&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;BACKGROUND:&lt;/strong&gt; The ANRS 12381 PRINCESSE project (11/2019-06/2023) enrolled 489 FSWs and implemented community-based sexual and reproductive health care, including PrEP, delivered through mobile clinics at prostitution sites in the San Pedro region. This presentation aims to describe PrEP trajectories and the factors associated with its use, focusing on &#8220;early adopters&#8221;.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;METHODS:&lt;/strong&gt; This analysis included 400 FSWs eligible for PrEP (HIV-negative, HBsAg-negative) enrolled up to December 2022 (&gt;6 months of follow-up). Clinical records were analyzed to describe PrEP cascade, follow-up, and PrEP trajectories. A multivariable logistic regression identified factors associated with PrEP early adopters.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;RESULTS:&lt;/strong&gt; Although 98% of eligible FSWs were interested in PrEP, only 62% initiated PrEP, and 39% renewed it at least once.&lt;br class='autobr' /&gt;
Follow-up was very short (&lt;6 months) for 48%, short (6-12 months) for 15%, seasonal (&gt;12 months with a gap of 6 months between two visits) for 31%, and regular (&gt;12 months with no gap) for 6%.&lt;br class='autobr' /&gt;
PrEP initiation was high among FSWs with regular (96%), seasonal (83%), or short (80%) follow-up, vs. 39% for those with very short follow-up. Among those who initiated, only 88% (regular), 70% (seasonal), 74% (short), and 35% (very short) renewed PrEP.&lt;br class='autobr' /&gt;
Among 148 FSWs with regular/seasonal follow-up, four PrEP trajectories were identified (cf. figure showing individual trajectories): 15% &#8220;never initiated&#8221; PrEP, 39% &#8220;initiated and were later not interested anymore&#8221;, 18% &#8220;re-initiated after non-interest&#8221;, and 28% &#8220;initiated and never expressed non-interest&#8221;, the last two groups being considered as &#8220;early adopters&#8221;. Factors associated with early PrEP adoption included the usual price of intercourse with clients &lt;1500 FCFA (aOR=2.4 [1.2-4.8]) and working in brothels (aOR=3.2 [1.6-6.6]).&lt;/p&gt;
&lt;dl class='spip_document_627 spip_documents spip_documents_center media media_vignette'&gt; &lt;dt&gt;&lt;a href='http://joseph.larmarange.net/IMG/png/figure_1000.png' class=&#034;spip_in&#034; title=&#034;Figure presenting individual PrEP trajectories of FSWs enrolled in the PRINCESSE project&#034; hreflang=&#034;&#034; type=&#034;image/png&#034;&gt;&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L240xH360/figure_1000-140af-7601a.png?1752596042' width='240' height='360' alt='Figure presenting individual PrEP trajectories of FSWs enrolled in the PRINCESSE project' /&gt;&lt;/a&gt;&lt;/dt&gt; &lt;dt class='spip_doc_titre crayon document-titre-627' style='max-width: 240px;'&gt;&lt;strong&gt;Figure presenting individual PrEP trajectories of FSWs enrolled in the PRINCESSE project&lt;/strong&gt;&lt;/dt&gt;&lt;/dl&gt;
&lt;p&gt;&lt;strong&gt;CONCLUSIONS:&lt;/strong&gt; In PRINCESSE, loss-to-follow-up and seasonality of risks limited PrEP adoption. FSWs who were more precarious and less mobile became early adopters of this new prevention tool and could serve as potential ambassadors for promoting its uptake.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
See also&lt;/h2&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5163769&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05163769v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163769v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Perceptions regarding long-acting pre-exposure prevention (PrEP) among female sex workers and men having sex with men in San Pedro and Abidjan, C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;IAS 2025, the 13th IAS Conference on HIV Science&lt;/i&gt;, Jul 2025, Kigali, Rwanda. &lt;a target=&#034;_blank&#034; href=&#034;https://programme.ias2025.org/Abstract/Abstract/?abstractid=4762&#034; rel=&#034;noreferrer noopener&#034;&gt;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-poster&#034;&gt;Poster de conf&#233;rence&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163769v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05163769&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>ANRS 12381 PRINCESSE @ AIDSImpact 2025: PrEP adoption &amp; perceptions of long acting PrEP</title>
		<link>http://joseph.larmarange.net/anrs-12381-princesse-aidsimpact</link>
		<guid isPermaLink="true">http://joseph.larmarange.net/anrs-12381-princesse-aidsimpact</guid>
		<dc:date>2025-05-30T14:21:01Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>Itin&#233;raires th&#233;rapeutiques</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Repr&#233;sentations / Perceptions</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Adoption of HIV preexposure prophylaxis (PrEP) among female sex workers (FSWs) in C&#244;te d'Ivoire: complex trajectories and early adopters &lt;br class='autobr' /&gt;
Introduction &lt;br class='autobr' /&gt;
The ANRS 12381 PRINCESSE project (November 2019 - June 2023) implemented community-based sexual and reproductive health care, including preexposure prophylaxis (PrEP), for female sex workers (FSWs) in the San Pedro region of C&#244;te d'Ivoire, delivered through mobile clinics at prostitution sites in the San Pedro region. This presentation aims&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="http://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="http://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Itineraires-therapeutiques-+" rel="tag"&gt;Itin&#233;raires th&#233;rapeutiques&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Representations-Perceptions-+" rel="tag"&gt;Repr&#233;sentations / Perceptions&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L150xH55/aidsimpact2025logo-047e2.png?1748616898' class='spip_logo spip_logo_right' width='150' height='55' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5090841&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05090841v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05090841v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Adoption of HIV preexposure prophylaxis (PrEP) among female sex workers (FSWs) in C&#244;te d'Ivoire: complex trajectories and early adopters&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;16th AIDSImpact Conference&lt;/i&gt;, AIDSImpact, May 2025, Casablanca, Morocco&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05090841v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05090841&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Adoption of HIV preexposure prophylaxis (PrEP) among female sex workers (FSWs) in C&#244;te d'Ivoire: complex trajectories and early adopters&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Introduction&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The ANRS 12381 PRINCESSE project (November 2019 - June 2023) implemented community-based sexual and reproductive health care, including preexposure prophylaxis (PrEP), for female sex workers (FSWs) in the San Pedro region of C&#244;te d'Ivoire, delivered through mobile clinics at prostitution sites in the San Pedro region. This presentation aims to describe PrEP trajectories and the factors associated with its use, focusing on &#8220;early adopters&#8221;.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;A total of 489 women were enrolled in the PRINCESSE cohort. This analysis included 400 FSWs eligible for PrEP (HIV-negative, HBsAg-negative at baseline) enrolled up to December 2022 (i.e. enrolled at least 6 months before cohort closure). Clinical records were analyzed to describe PrEP cascade, follow-up, and PrEP trajectories. A multivariable logistic regression identified factors associated with PrEP early adopters.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The overall PrEP cascade showed that although 98% of eligible FSWs were interested in PrEP, only 62% initiated PrEP, and 39% renewed it at least once.&lt;/p&gt;
&lt;p&gt;Follow-up was very short (&lt;6 months) for 48% of FSWs, short (6-12 months) for 15%, seasonal (&gt;12 months with a gap of 6 months between two visits) for 31%, and regular (&gt;12 months with no gap) for 6%.&lt;/p&gt;
&lt;p&gt;PrEP initiation was high among FSWs with regular (96%), seasonal (83%), or short (80%) follow-up, vs. 39% for those with very short follow-up. Among those who initiated, only 88% (regular), 70% (seasonal), 74% (short), and 35% (very short) renewed PrEP.&lt;/p&gt;
&lt;p&gt;Among 148 FSWs with regular/seasonal follow-up, four PrEP trajectories were identified (cf. attached figure showing individual trajectories, each line representing a participant's PrEP journey): 15% never initiated PrEP; 39% initiated PrEP before stopping and expressing they were not interested anymore; 18% re-initiated PrEP after an episode of non-interest&#8221;; and 28% initiated and never expressed non-interest at a later stage. The last two groups were considered as &#8220;early adopters&#8221;. Significant factors associated with early PrEP adoption were the usual price of intercourse with clients &lt;1500 FCFA (i.e. 2.3 EUR) (aOR=2.4 [1.2-4.8]) and working in brothels (aOR=3.2 [1.6-6.6]).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;In PRINCESSE, loss-to-follow-up and seasonality of risks limited PrEP adoption. FSWs who were more precarious and less mobile became early adopters of this new prevention tool and could serve as potential ambassadors for promoting its uptake and demand creation.&lt;/p&gt;
&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5090784&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05090784v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05090784v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Perception de la Prophylaxie pr&#233;exposition &#224; longue dur&#233;e d'action chez les travailleuses du sexe et les HSH &#224; San Pedro et Abidjan, C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;16th AIDSImpact Conference&lt;/i&gt;, AIDSImpact, May 2025, Casablanca, Maroc&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05090784v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05090784&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;div lang='fr'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Perception de la Prophylaxie pr&#233;exposition &#224; longue dur&#233;e d'action chez les travailleuses du sexe et les HSH &#224; San Pedro et Abidjan, C&#244;te d'Ivoire&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Introduction&#160;:&lt;/strong&gt; Des recherches ont montr&#233; que l'utilisation et l'adh&#233;sion &#224; la PrEP par voie orale peuvent &#234;tre complexes au sein de certaines populations, telles que les travailleuses du sexe (TS) et les hommes ayant des relations sexuelles avec d'autres hommes (HSH), notamment en raison de leur grande mobilit&#233;, d'une vie quotidienne impr&#233;visible ou d'effets secondaires. Dans ce contexte, la PrEP &#224; longue dur&#233;e d'action (actuellement &#224; diff&#233;rents stades de d&#233;veloppement), telle que les injectables, le gel, les implants, les suppositoires vaginaux, les douches vaginales/anales ou les anneaux vaginaux, pourraient contribuer &#224; surmonter certaines difficult&#233;s rencontr&#233;es avec la PrEP orale. Cette &#233;tude visait &#224; explorer les perceptions de ces formulations &#224; longue dur&#233;e d'action parmi les TS et les HSH en C&#244;te d'Ivoire.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;M&#233;thodologie&#160;:&lt;/strong&gt; Inscrite dans le projet ANRS 12381 PRINCESSE, cette sous-&#233;tude qualitative a &#233;t&#233; men&#233;e en novembre-d&#233;cembre 2023 au sein de deux ONG communautaires&#160;: Aprosam &#224; San Pedro et Espace Confiance &#224; Abidjan aupr&#232;s des TS et HSH. Au total, 32 TS (19 na&#239;ves de PrEP et 13 exp&#233;riment&#233;es) et 12 HSH (3 na&#239;fs de PrEP et 9 exp&#233;riment&#233;s) ont &#233;t&#233; interrog&#233;s (lors de14 entretiens individuels et 5 focus groups). Une analyse th&#233;matique s'est concentr&#233;e sur l'aspect pratique, la discr&#233;tion, l'autonomie, l'efficacit&#233; per&#231;ue et les effets secondaires anticip&#233;s des diff&#233;rentes formulations de PrEP &#224; longue dur&#233;e d'action.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;R&#233;sultats&#160;:&lt;/strong&gt; Les participants ont g&#233;n&#233;ralement exprim&#233; des opinions favorables &#224; l'&#233;gard de la PrEP &#224; longue dur&#233;e d'action, consid&#233;r&#233;e comme une forme moins contraingrante que la PrEP par voie orale. Les injections ont &#233;t&#233; particuli&#232;rement appr&#233;ci&#233;es pour leur discr&#233;tion (pas de marque visible), les injections semestrielles &#233;tant pr&#233;f&#233;r&#233;es. Quelques inqui&#233;tudes ont &#233;t&#233; exprim&#233;es quant &#224; la douleur li&#233;e &#224; l'injection. Le gel, assimil&#233; &#224; un lubrifiant, a s&#233;duit par sa double fonction de protection et de plaisir. Toutefois, certains participants ont exprim&#233; des doutes quant &#224; son efficacit&#233;. Bien que la dur&#233;e d'action de l'implant (1 an) ait &#233;t&#233; appr&#233;ci&#233;e, elle n'a pas &#233;t&#233; pl&#233;biscit&#233;e en raison du manque de discr&#233;tion (cicatrice) et des effets secondaires potentiels anticip&#233;s. L'autonomie et la facilit&#233; d'utilisation des suppositoires vaginaux sont per&#231;ues comme avantageuses, &#224; condition que les conditions d'hygi&#232;ne soient optimales&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; les HSH font le parall&#232;le avec les suppositoires anaux. M&#234;me si les douches vaginales sont largement pratiqu&#233;es par les TS, la lotion de nettoyage intime de la PrEP a re&#231;u des r&#233;actions mitig&#233;es de la part des TS, conscientes des risques d'un usage excessif. Enfin, l'anneau vaginal a suscit&#233; peu d'int&#233;r&#234;t en raison de la m&#233;connaissance de l'outil.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion&#160;:&lt;/strong&gt; Dans l'ensemble, la PrEP &#224; longue dur&#233;e d'action peut offrir des options alternatives pour la pr&#233;vention du VIH. Les &#233;l&#233;ments cl&#233;s favorisant l'adoption &#224; un format (PrEP &#224; longue dur&#233;e d'action) sont la facilit&#233; d'utilisation, un suivi simplifi&#233; (le moins souvent possible), des r&#232;gles claires pour le d&#233;marrage et l'arr&#234;t, la discr&#233;tion, l'efficacit&#233; per&#231;ue et les effets secondaires anticip&#233;s.&lt;/p&gt;
&lt;/div&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>Retrait du Pepfar&#160;: jusqu'&#224; 56000 d&#233;c&#232;s suppl&#233;mentaires en Afrique de l'Ouest</title>
		<link>http://joseph.larmarange.net/retrait-du-pepfar-jusqu-a-56000</link>
		<guid isPermaLink="true">http://joseph.larmarange.net/retrait-du-pepfar-jusqu-a-56000</guid>
		<dc:date>2025-04-30T15:02:44Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Mod&#233;lisation de l'impact d'un retrait du Pepfar</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Mali</dc:subject>
		<dc:subject>S&#233;n&#233;gal</dc:subject>
		<dc:subject>Financement des programmes</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>Pepfar</dc:subject>
		<dc:subject>Politiques publiques</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Article de Fred&#233;rique Prabonnaud publi&#233; le 21&#160;avril 2025 dans transveral, un magazine de Sidaction. Cet article pr&#233;sente des r&#233;sultats pr&#233;liminaires du projet Mod&#233;lisation de l'impact &#233;pid&#233;miologique potentiel du retrait du PEPFAR en C&#244;te d'Ivoire, au Mali et au S&#233;n&#233;gal. &lt;br class='autobr' /&gt; L'arr&#234;t comme la suspension du programme am&#233;ricain PEPFAR entra&#238;nera des cons&#233;quences sur l'&#233;pid&#233;mie de VIH en Afrique de l'Ouest&#160;: c'est la conclusion d'une mod&#233;lisation dont les r&#233;sultats pr&#233;liminaires ont &#233;t&#233; pr&#233;sent&#233;s&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="http://joseph.larmarange.net/-Divers-" rel="directory"&gt;Divers&lt;/a&gt;

/ 
&lt;a href="http://joseph.larmarange.net/+-modelisation-de-l-impact-d-un-+" rel="tag"&gt;Mod&#233;lisation de l'impact d'un retrait du Pepfar&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Mali-+" rel="tag"&gt;Mali&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Senegal-+" rel="tag"&gt;S&#233;n&#233;gal&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Financement-des-programmes-+" rel="tag"&gt;Financement des programmes&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-pepfar-+" rel="tag"&gt;Pepfar&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Politiques-publiques-+" rel="tag"&gt;Politiques publiques&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='http://joseph.larmarange.net/IMG/logo/exposition-vihsida-lepidemie-nest-pas-finie-au-mucem-a-marseille-690x765.webp?1746025288' class='spip_logo spip_logo_right' width='135' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Article de Fred&#233;rique Prabonnaud publi&#233; le 21&#160;avril 2025 dans &lt;i&gt;transveral&lt;/i&gt;, un magazine de Sidaction. Cet article pr&#233;sente des r&#233;sultats pr&#233;liminaires du projet &lt;a href='http://joseph.larmarange.net/modelisation-de-l-impact' class=&#034;spip_in&#034;&gt;Mod&#233;lisation de l'impact &#233;pid&#233;miologique potentiel du retrait du PEPFAR en C&#244;te d'Ivoire, au Mali et au S&#233;n&#233;gal&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;p&gt;L'arr&#234;t comme la suspension du programme am&#233;ricain PEPFAR entra&#238;nera des cons&#233;quences sur l'&#233;pid&#233;mie de VIH en Afrique de l'Ouest&#160;: c'est la conclusion d'une mod&#233;lisation dont les r&#233;sultats pr&#233;liminaires ont &#233;t&#233; pr&#233;sent&#233;s lors des journ&#233;es scientifiques de l'ANRS-MIE. Des r&#233;sultats particuli&#232;rement alarmants pour le S&#233;n&#233;gal et la C&#244;te d'Ivoire.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>La fin du sida est-elle toujours en vue&#160;?</title>
		<link>http://joseph.larmarange.net/la-fin-du-sida-est-elle-toujours</link>
		<guid isPermaLink="true">http://joseph.larmarange.net/la-fin-du-sida-est-elle-toujours</guid>
		<dc:date>2025-03-27T10:47:15Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Financement des programmes</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>Pepfar</dc:subject>
		<dc:subject>Politiques publiques</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Science de la mise en &#339;uvre </dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;La fin du sida est-elle toujours en vue&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? &lt;br class='autobr' /&gt; Joseph Larmarange Journ&#233;e Scientifique Sidaction 2025, Sidaction, Mar 2025, Paris, France Communication dans un congr&#232;s hal-05008296 &lt;br class='autobr' /&gt;
Pl&#233;ni&#232;re d'ouverture de Journ&#233;e scientifique Sidaction 2025, le 27&#160;mars 2025 &#224; Paris.&lt;/p&gt;


-
&lt;a href="http://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="http://joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Financement-des-programmes-+" rel="tag"&gt;Financement des programmes&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-pepfar-+" rel="tag"&gt;Pepfar&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Politiques-publiques-+" rel="tag"&gt;Politiques publiques&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-science-de-la-mise-en-oeuvre-+" rel="tag"&gt;Science de la mise en &#339;uvre &lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L150xH100/pexels-xperimental-978844-10beb.jpg?1743072933' class='spip_logo spip_logo_right' width='150' height='100' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5008311&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05008296v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05008296v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;La fin du sida est-elle toujours en vue ?&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;Journ&#233;e Scientifique Sidaction 2025&lt;/i&gt;, Sidaction, Mar 2025, Paris, France&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05008296v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05008296&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;
&lt;p&gt;Pl&#233;ni&#232;re d'ouverture de &lt;a href=&#034;https://www.sidaction.org/action/soutenir-la-recherche/journee-scientifique-sidaction/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;Journ&#233;e scientifique Sidaction 2025&lt;/a&gt;, le 27&#160;mars 2025 &#224; Paris.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="http://joseph.larmarange.net/IMG/pdf/sidaction_larmarange_2025-03-27.pdf" length="3960097" type="application/pdf" />
		

	</item>
<item xml:lang="fr">
		<title>Mod&#233;lisation de l'impact &#233;pid&#233;miologique potentiel du retrait du PEPFAR en C&#244;te d'Ivoire, au Mali et au S&#233;n&#233;gal</title>
		<link>http://joseph.larmarange.net/modelisation-de-l-impact</link>
		<guid isPermaLink="true">http://joseph.larmarange.net/modelisation-de-l-impact</guid>
		<dc:date>2025-03-20T13:03:45Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Mali</dc:subject>
		<dc:subject>S&#233;n&#233;gal</dc:subject>
		<dc:subject>Mod&#233;lisation de l'impact d'un retrait du Pepfar</dc:subject>
		<dc:subject>Financement des programmes</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>Mod&#233;lisation</dc:subject>
		<dc:subject>Politiques publiques</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Pepfar</dc:subject>

		<description>
&lt;p&gt;Responsables scientifiques LARMARANGE Joseph, Ceped NIANGORAN Serge, PAC-CI SILHOL Romain, Imperial College London &lt;br class='autobr' /&gt;
Partenaires Imperial College London &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; https://www.imperial.ac.uk/ PAC-CI (programme ANRS de C&#244;te d'Ivoire) &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; https://web.pac-ci.org/ Universit&#233; Mac Gill &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; https://www.mcgill.ca/ &lt;br class='autobr' /&gt;
Membres du projet BOILY Marie-Claude, Imperial College London LARMARANGE Joseph, IRD / Ceped MAHEU-GIROUX Mathieu, McGill University MIAN Anatole, PAC-CI MOH Raoul, PAC-CI NIANGORAN Serge, PAC-CI&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="http://joseph.larmarange.net/-Projets-de-Recherche-" rel="directory"&gt;Projets de Recherche&lt;/a&gt;

/ 
&lt;a href="http://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Mali-+" rel="tag"&gt;Mali&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Senegal-+" rel="tag"&gt;S&#233;n&#233;gal&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-modelisation-de-l-impact-d-un-+" rel="tag"&gt;Mod&#233;lisation de l'impact d'un retrait du Pepfar&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Financement-des-programmes-+" rel="tag"&gt;Financement des programmes&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Modelisation-+" rel="tag"&gt;Mod&#233;lisation&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Politiques-publiques-+" rel="tag"&gt;Politiques publiques&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-pepfar-+" rel="tag"&gt;Pepfar&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L150xH83/dreamstime_xxl_62834246-full-seo-37495.jpg?1742477926' class='spip_logo spip_logo_right' width='150' height='83' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Responsables scientifiques&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; &lt;strong&gt;LARMARANGE Joseph&lt;/strong&gt;, Ceped&lt;/li&gt;&lt;li&gt; &lt;strong&gt;NIANGORAN Serge&lt;/strong&gt;, PAC-CI&lt;/li&gt;&lt;li&gt; &lt;strong&gt;SILHOL Romain&lt;/strong&gt;, Imperial College London&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Partenaires&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Imperial College London &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; &lt;a href=&#034;https://www.imperial.ac.uk/&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;https://www.imperial.ac.uk/&lt;/a&gt;&lt;/li&gt;&lt;li&gt; PAC-CI (programme ANRS de C&#244;te d'Ivoire) &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; &lt;a href=&#034;https://web.pac-ci.org/&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;https://web.pac-ci.org/&lt;/a&gt;&lt;/li&gt;&lt;li&gt; Universit&#233; Mac Gill &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; &lt;a href=&#034;https://www.mcgill.ca/&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;https://www.mcgill.ca/&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Membres du projet&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; &lt;strong&gt;BOILY Marie-Claude&lt;/strong&gt;, Imperial College London&lt;/li&gt;&lt;li&gt; &lt;strong&gt;LARMARANGE Joseph&lt;/strong&gt;, IRD / Ceped&lt;/li&gt;&lt;li&gt; &lt;strong&gt;MAHEU-GIROUX Mathieu&lt;/strong&gt;, McGill University&lt;/li&gt;&lt;li&gt; &lt;strong&gt;MIAN Anatole&lt;/strong&gt;, PAC-CI&lt;/li&gt;&lt;li&gt; &lt;strong&gt;MOH Raoul&lt;/strong&gt;, PAC-CI&lt;/li&gt;&lt;li&gt; &lt;strong&gt;NIANGORAN Serge&lt;/strong&gt;, PAC-CI&lt;/li&gt;&lt;li&gt; &lt;strong&gt;SILHOL Romain&lt;/strong&gt;, Imperial College London&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Financement&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; ANRS|MIE&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
R&#233;sum&#233;&lt;/h2&gt;
&lt;p&gt;La d&#233;cision de la nouvelle administration am&#233;ricaine d'interrompre le financement du plan pr&#233;sidentiel d'urgence pour la lutte contre le Sida (PEPFAR), officiellement pour une dur&#233;e minimale de 90 jours &#224; partir du 20&#160;Janvier 2025, pourrait avoir des effets d&#233;vastateurs sur les populations vivant en Afrique de l'Ouest. En effet, ces fonds apportaient une aide vitale, non seulement en finan&#231;ant plus de la moiti&#233; de l'acc&#232;s au diagnostic et traitement antir&#233;troviral contre le VIH aupr&#232;s des populations vivant avec le VIH (PVVIH), mais supportait &#233;galement de nombreux programmes de pr&#233;vention de l'infection VIH, notamment parmi les populations cl&#233;s (i.e., les plus touch&#233;es par le VIH), comme les travailleuses du sexe (TS) et les hommes ayant des rapports sexuels avec d'autres hommes (HSH). Ces financements am&#233;ricains, conjugu&#233;s aux efforts nationaux des pays d'Afrique de l'Ouest et de la communaut&#233; internationale, ont permis de diminuer de moiti&#233; le nombre de nouvelles infections et d&#233;c&#232;s dus au VIH entre 2010 et 2023 dans la r&#233;gion.&lt;/p&gt;
&lt;p&gt;Afin d'alerter l'opinion et les pouvoirs politiques et scientifiques, il est urgent de&lt;/p&gt;
&lt;ol class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Comprendre l'impact &#233;pid&#233;miologique (nouvelles infections, d&#233;c&#232;s) de l'interruption et ou/arr&#234;t de ce support afin de plaider pour une reprise de l'aide am&#233;ricaine et/ou d'un support europ&#233;en additionnel&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;;&lt;/li&gt;&lt;li&gt; Identifier les activit&#233;s de pr&#233;vention et de traitement du VIH dont le maintien doit &#234;tre consid&#233;r&#233; comme une priorit&#233; afin de minimiser l'impact du retrait PEPFAR&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;;&lt;/li&gt;&lt;li&gt; &#201;valuer quelles populations pourraient &#234;tre les plus affect&#233;es par ce retrait, en s'appuyant sur des donn&#233;es stratifi&#233;es par population cl&#233;, transmises par des programmes nationaux de lutte nationale contre le sida, ainsi que les organisations non-gouvernementales impl&#233;mentant ces politiques sur le terrain.&lt;/li&gt;&lt;/ol&gt;
&lt;p&gt;Pour ce projet, nous proposons d'adapter et utiliser le mod&#232;le &#233;pid&#233;miologique d&#233;velopp&#233; dans le projet ATLAS pour simuler le cours de l'&#233;pid&#233;mie VIH pour la p&#233;riode 1980-2040 (prenant d'abord pour hypoth&#232;se contrefactuelle un maintien des activit&#233;s PEPFAR au cours du temps), compar&#233; &#224; des scenarios de diminution des niveaux de pr&#233;vention, diagnostic et traitement du VIH au cours de 2025-2040, au sein de chaque pays. Ce mod&#232;le a &#233;t&#233; r&#233;cemment calibr&#233; pour repr&#233;senter les dynamiques de transmission et contr&#244;le du VIH au cours du temps en C&#244;te d'Ivoire, au Mali et au S&#233;n&#233;gal s&#233;par&#233;ment, afin de pr&#233;dire les dynamiques futures les plus plausibles.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Mots-Cl&#233;s&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Lutte contre le VIH, Pepfar, politiques publiques, mod&#233;lisations &#233;pid&#233;miologiques&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Pays&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;C&#244;te d'Ivoire, Mali, S&#233;n&#233;gal&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Calendrier&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;2025&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Syndromic and biological screening for sexually transmitted infections in female sex workers in C&#244;te d'Ivoire: the ANRS 12381 PRINCESSE cohort study</title>
		<link>http://joseph.larmarange.net/syndromic-and-biological-screening</link>
		<guid isPermaLink="true">http://joseph.larmarange.net/syndromic-and-biological-screening</guid>
		<dc:date>2025-03-13T17:07:15Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>&#201;pid&#233;miologie</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Marcellin N'zebo Nouaman, Patrick Ahuatchi Coffie, Aline Agoua, Cl&#233;mence Z&#233;bago, Herv&#233; Dao, Evelyne Kissi, S&#233;verin Lenaud, Mian Anatole, Valentine Becquet, M&#233;lanie Plazy, Fran&#231;ois Dabis, Serge Eholie, Joseph Larmarange for the ANRS 12381 Princesse Study group &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Background: Female sex workers (FSWs) are at high risk of contracting STIs, in particular in Sub-Saharan Africa. The implementation of oral HIV pre-exposure prophylaxis provided an opportunity to draw attention to&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="http://joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="http://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Epidemiologie-+" rel="tag"&gt;&#201;pid&#233;miologie&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L150xH111/princesse-9c71c.jpg?1741888608' class='spip_logo spip_logo_right' width='150' height='111' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4990249&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04990223v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-4596acf7-a3a62.png?1741981009' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04990223v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Syndromic and biological screening for sexually transmitted infections in female sex workers in C&#244;te d'Ivoire: the ANRS 12381 PRINCESSE cohort study&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marcellin+N%E2%80%99zebo+Nouaman&#034; class=&#034;hal-auteur&#034;&gt;Marcellin N'zebo Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Patrick+Ahuatchi+Coffie&#034; class=&#034;hal-auteur&#034;&gt;Patrick Ahuatchi Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Aline+Agoua&#034; class=&#034;hal-auteur&#034;&gt;Aline Agoua&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Cl%C3%A9mence+Z%C3%A9bago&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Z&#233;bago&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Herv%C3%A9+Dao&#034; class=&#034;hal-auteur&#034;&gt;Herv&#233; Dao&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=S%C3%A9verin+Lenaud&#034; class=&#034;hal-auteur&#034;&gt;S&#233;verin Lenaud&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Mian+Anatole&#034; class=&#034;hal-auteur&#034;&gt;Mian Anatole&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Valentine+Becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196998&#034; class=&#034;hal-auteur&#034;&gt;Fran&#231;ois Dabis&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Serge+Eholie&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;Frontiers in Public Health&lt;/i&gt;, 2025, 13, &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.3389/fpubh.2025.1535122&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.3389/fpubh.2025.1535122&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04990223v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04990223&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Marcellin N'zebo Nouaman, Patrick Ahuatchi Coffie, Aline Agoua, Cl&#233;mence Z&#233;bago, Herv&#233; Dao, Evelyne Kissi, S&#233;verin Lenaud, Mian Anatole, Valentine Becquet, M&#233;lanie Plazy, Fran&#231;ois Dabis, Serge Eholie, Joseph Larmarange for the ANRS 12381 Princesse Study group&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Background:&lt;/strong&gt; Female sex workers (FSWs) are at high risk of contracting STIs, in particular in Sub-Saharan Africa. The implementation of oral HIV pre-exposure prophylaxis provided an opportunity to draw attention to the sexual health needs of FSWs. Innovative strategies to screen for and reduce the burden of STIs is thus a priority. This study describes STI screening among FSWs enrolled in the PRINCESSE project in C&#244;te d'Ivoire.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods:&lt;/strong&gt; The PRINCESSE project (2019&#8211;2023) was an interventional cohort of FSWs &#8805;18&#8239;years, evaluating a comprehensive, community-based sexual and reproductive health care package, including the management of STIs, offered through mobile clinics operating on prostitution sites in San Pedro area. HIV testing and syndromic STI testing were offered at baseline and every 3&#8239;months. Biological testing of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) was offered annually. Clinical forms included sociodemographic, behavioral and sex-work-related characteristics. We describe baseline characteristics, coverage of clinical examination, and vaginal, anal swab collection. Social, behavioral and sex work-related factors associated with an STI syndromic diagnosis were explored. A multivariable logistic regression model was used to identify factors associated with diagnosing a symptomatic STI.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results:&lt;/strong&gt; 489 FSWs were included in the PRINCESSE cohort. Median age was 29&#8239;years (24&#8211;35&#8239;years), 28.6% had had sex without a condom in the last 7&#8239;days. The prevalence of HIV at baseline was 10.5%. Only one case of HIV seroconversion was observed during the project. The most frequent symptom was ano-vaginal discharge (19.1%). The prevalence of STI based on clinical symptoms was 26.6%. The proportion of vaginal swab samples for which the PCR result was positive was 8.0% for CT and 4.0% for NG. Only age remained significantly associated with diagnosing a symptomatic STI in the multivariable analysis.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt; This study revealed a high prevalence of HIV and STIs, similar to national estimates among FSWs enrolled in a sexual health cohort. Screening for these generically asymptomatic bacterial STIs must be combined with the syndromic approach used in key populations, especially with the introduction of new PrEP programs, to reduce the exposure of individuals in these populations to STIs.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>VIH&#160;: des solutions pr&#233;ventives &#224; longue dur&#233;e prometteuses</title>
		<link>http://joseph.larmarange.net/vih-des-solutions-preventives-a</link>
		<guid isPermaLink="true">http://joseph.larmarange.net/vih-des-solutions-preventives-a</guid>
		<dc:date>2024-12-02T17:58:04Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;La PrEP avec le l&#233;nacapavir injectable est une solution efficace et prometteuse pour les populations vuln&#233;rables, &#224; condition d'&#234;tre accessible. &lt;br class='autobr' /&gt;
Des outils de pr&#233;vention toujours plus efficaces et moins contraignants, adapt&#233;s aux conditions de vie et besoins r&#233;els des populations les plus expos&#233;es&#160;: voil&#224; le nerf de la guerre contre le VIH. Parmi eux, la PrEP avec le l&#233;nacapavir nourrit de grands espoirs comme outil de pr&#233;vention. Ce m&#233;dicament est d&#233;j&#224; utilis&#233; pour soigner les patients&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="http://joseph.larmarange.net/-Divers-" rel="directory"&gt;Divers&lt;/a&gt;

/ 
&lt;a href="http://joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L150xH56/img_20210903_124636_0-b22da.jpg?1733163509' class='spip_logo spip_logo_right' width='150' height='56' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4815260&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04815258v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-03b53679-98aa0.png?1733856007' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04815258v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;VIH : des solutions pr&#233;ventives &#224; longue dur&#233;e prometteuses&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Louise+Hurel&#034; class=&#034;hal-auteur&#034;&gt;Louise Hurel&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731241921&#034; class=&#034;hal-auteur&#034;&gt;Christian Laurent&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/karna-coulibaly&#034; class=&#034;hal-auteur&#034;&gt;Karna Coulibaly&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;2024&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-blog&#034;&gt;Article de blog scientifique&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04815258v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04815258&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;
&lt;p&gt;&lt;strong&gt;La PrEP avec le l&#233;nacapavir injectable est une solution efficace et prometteuse pour les populations vuln&#233;rables, &#224; condition d'&#234;tre accessible.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Des outils de pr&#233;vention toujours plus efficaces et moins contraignants, adapt&#233;s aux conditions de vie et besoins r&#233;els des populations les plus expos&#233;es&#160;: voil&#224; le nerf de la guerre contre le VIH. Parmi eux, la PrEP avec le l&#233;nacapavir nourrit de grands espoirs comme outil de pr&#233;vention. Ce m&#233;dicament est d&#233;j&#224; utilis&#233; pour soigner les patients ayant d&#233;velopp&#233; des r&#233;sistances aux traitements les plus courants. Deux &#233;tudes viennent de d&#233;montrer qu'il &#233;tait &#233;galement pleinement efficace pour emp&#234;cher les nouvelles infections, &#224; raison d'une injection sous-cutan&#233;e tous les six mois. Une r&#233;volution dans le domaine de la pr&#233;vention&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;!&lt;/p&gt;
&lt;p&gt;En quoi le l&#233;nacapavir injectable peut apporter une solution p&#233;renne&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? &#192; qui et sous quelles conditions&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;?&lt;/p&gt;
&lt;p&gt;Explications avec trois scientifiques impliqu&#233;s dans des projets de recherche aupr&#232;s de populations cl&#233;s&#160;: Christian Laurent, &#233;pid&#233;miologiste IRD &#224; TransVIHMI, coordinateur du projet CohMSM-PrEP, centr&#233; sur les hommes ayant des rapports sexuels avec les hommes (HSH) en Afrique de l'Ouest&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; Joseph Larmarange, d&#233;mographe IRD au Ceped, coordinateur du projet Princesse aupr&#232;s de travailleuses du sexe en C&#244;te d'Ivoire&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; et Karna Coulibaly, d&#233;mographe Ined et chercheur associ&#233; au Ceped, impliqu&#233; dans le projet Makasi qui a &#233;t&#233; r&#233;alis&#233; aupr&#232;s d'immigr&#233;s d'Afrique subsaharienne en situation de pr&#233;carit&#233; vivant en &#206;le-de-France.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>Building better HIV models&#160;: a framework for incorporating evidence on structural determinants and interventions to estimate their impacts on HIV epidemics</title>
		<link>http://joseph.larmarange.net/building-better-hiv-models-a</link>
		<guid isPermaLink="true">http://joseph.larmarange.net/building-better-hiv-models-a</guid>
		<dc:date>2024-10-28T15:41:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>Mod&#233;lisation</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Poster presented at HIVR4P 2024, the 5th HIV Research for Prevention Conference, October 2024, Lima, Peru. &lt;br class='autobr' /&gt;
Authors &lt;br class='autobr' /&gt;
James Stannah, Jorge Luis Flores Anato, Michael Pickles, Joseph Larmarange, Kate M.&#160;Mitchell, Adelina Artenie, Kostyantyn Dumchev, Serge Niangoran, Lucy Platt, Fern Terris-Prestholt Terris-Prestholt, Amteshwar Singh, Jack Stone, Peter Vickerman, Andrew Phillips, Leigh F Johnson, Mathieu Maheu-Giroux, Marie-Claude Boily &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
BACKGROUND&#160;: Structural determinants (SDs)&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="http://joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="http://joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-Modelisation-+" rel="tag"&gt;Mod&#233;lisation&lt;/a&gt;, 
&lt;a href="http://joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='http://joseph.larmarange.net/IMG/logo/hivr4p_2024.webp?1740757236' class='spip_logo spip_logo_right' width='150' height='113' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Poster presented at &lt;i&gt;HIVR4P 2024, the 5th HIV Research for Prevention Conference&lt;/i&gt;, October 2024, Lima, Peru.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4971986&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04971981v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='http://joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-29c6b158-22869.png?1740849108' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04971981v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Building better HIV models: a framework for incorporating evidence on structural determinants and interventions to estimate their impacts on HIV epidemics&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=James+Stannah&#034; class=&#034;hal-auteur&#034;&gt;James Stannah&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Jorge+Luis+Flores+Anato&#034; class=&#034;hal-auteur&#034;&gt;Jorge Luis Flores Anato&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Michael+Pickles&#034; class=&#034;hal-auteur&#034;&gt;Michael Pickles&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Kate+M.+Mitchell&#034; class=&#034;hal-auteur&#034;&gt;Kate M. Mitchell&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Adelina+Artenie&#034; class=&#034;hal-auteur&#034;&gt;Adelina Artenie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Kostyantyn+Dumchev&#034; class=&#034;hal-auteur&#034;&gt;Kostyantyn Dumchev&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Serge+Niangoran&#034; class=&#034;hal-auteur&#034;&gt;Serge Niangoran&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673888222&#034; class=&#034;hal-auteur&#034;&gt;Lucy Platt&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673890157&#034; class=&#034;hal-auteur&#034;&gt;Fern Terris-Prestholt Terris-Prestholt&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Amteshwar+Singh&#034; class=&#034;hal-auteur&#034;&gt;Amteshwar Singh&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Jack+Stone&#034; class=&#034;hal-auteur&#034;&gt;Jack Stone&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731278232&#034; class=&#034;hal-auteur&#034;&gt;Peter Vickerman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731182296&#034; class=&#034;hal-auteur&#034;&gt;Andrew Phillips&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Leigh+F+Johnson&#034; class=&#034;hal-auteur&#034;&gt;Leigh F Johnson&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/mathieumg&#034; class=&#034;hal-auteur&#034;&gt;Mathieu Maheu-Giroux&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197204&#034; class=&#034;hal-auteur&#034;&gt;Marie-Claude Boily&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;HIVR4P 2024, the 5th HIV Research for Prevention Conference&lt;/i&gt;, Oct 2024, Lima, Peru&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-poster&#034;&gt;Poster de conf&#233;rence&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04971981v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04971981&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;James Stannah, Jorge Luis Flores Anato, Michael Pickles, Joseph Larmarange, Kate M.&#160;Mitchell, Adelina Artenie, Kostyantyn Dumchev, Serge Niangoran, Lucy Platt, Fern Terris-Prestholt Terris-Prestholt, Amteshwar Singh, Jack Stone, Peter Vickerman, Andrew Phillips, Leigh F Johnson, Mathieu Maheu-Giroux, Marie-Claude Boily&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;BACKGROUND&#160;:&lt;/strong&gt; Structural determinants (SDs) are social, economic, political, cultural, organizational, and environmental factors that shape HIV inequalities across individuals and populations. UNAIDS' 10-10-10 targets aim to reduce exposure to SDs including punitive regulations, violence, stigma, and discrimination. Evidence-based dynamic HIV transmission models can help quantify the population-level impacts of SDs and structural interventions to inform decision-making. We appraised previous representations of SDs in HIV models to develop a new framework that supports the modelling and analysis of SDs.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;METHODS&#160;:&lt;/strong&gt; We performed a scoping review of HIV transmission dynamic modelling studies that modelled SDs, published until August 28, 2023, using Ovid Embase and Medline databases. To develop our framework, we considered how models represented exposures to SDs (statically vs dynamically) and reproduced causal pathways to estimate impacts on HIV, and the data they used.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;RESULTS&#160;:&lt;/strong&gt; We found 17 HIV modelling studies of SDs and/or structural interventions including incarceration of people who inject drugs (n=5) or Black men (n=2), violence against women (n=3), HIV-stigma (n=1), and homelessness (n=1), among other less well-defined exposures (e.g., &#8220;positive and negative attitudes&#8221;). Eight studies modelled SDs dynamically using granular exposure histories (e.g., current, recent, non-recent) that captured variation in duration and intensity of exposure. SDs mostly influenced HIV indirectly through simple causal pathways with single intermediate variables (mediators) &#8211; largely sexual/injecting partner numbers (n=9), mixing patterns (n=8), or condom use (n=6). Effects of SDs were mostly informed by cross-sectional data. Only seven studies fitted to observed trends in SDs or their effects on mediators/HIV. Using this, we developed our framework (Figure).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;CONCLUSIONS&#160;:&lt;/strong&gt; The representation of SDs in models could be refined to improve projections of their impacts and interventions using our framework. Fundamentally, this requires better inputs&#160;: more longitudinal studies investigating heterogeneity in SDs and their causal effects. Methods, findings, and limitations should be transparently communicated.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="http://joseph.larmarange.net/IMG/pdf/ep209.pdf" length="801906" type="application/pdf" />
		

	</item>



</channel>

</rss>
